Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

This Canadian Biopharmaceutical Co. is a Pioneer of the Medical Cannabis Industry

An evidence-based, scientific approach is how Avicanna Inc. ( TSX.AVCN , OTC: AVCNF , Forum ) gains its competitive advantage in the medical cannabis sector. The Canadian biopharmaceutical company has spent over four years in research & development before creating its m...
Isabella Zavarise | December 22, 2020 |

InMed Shares Trade Up 25% After Becoming First to Advance Cannabinol into Clinical Trials

InMed Pharmaceuticals shares traded 25% higher after reporting that it is the first to advance cannabinol into therapeutic clinical trials. Vancouver-based clinical stage biopharmaceutical company InMed Pharmaceuticals Inc. (IN:TSX; IMLFF:OTCQX) , which is engaged in...
Streetwise Reports | January 21, 2020 |

Thematica Report: Investing in undervalued stocks

The Market Herald launches Thematica's latest report: Unlocking the Advantages of Undervalued Stocks. Download it today!
Jocelyn Aspa | November 29, 2022 |

Aleafia Health CEO Talks Expansion Plans and Progress

(Image via Aleafia Health. Click image to enlarge) When a business strategy works and can be expanded, the smart bet is to double down. That’s the logic in any industry, and the still-growing cannabis market is no different. That&CloseCurlyQuote...
Omri Wallach | September 27, 2019 |

Exicure's Collaboration with Allergan on Treating Hair Loss Disorders Sends Shares Higher

Shares of Exicure Inc. opened 30% higher today after the firm reported that it entered into a collaboration agreement with Allergan to discover and develop SNA-based treatments for hair loss disorders. The terms of the deal provide for a $25 million upfront payment to Exicure ...
Streetwise Reports | November 15, 2019 |

Medcolcanna Prepares For Recurring Commercial Shipments

An Operational Update for 2021 as The Company Prepares for Recurring Shipments Medcolcanna Organics Inc. (NEO: MCCN), a leading Colombian and globally integrated cannabis company, is providing the following corporate update. Key highlights include: Capacity &...
Featured Submission | January 25, 2021 |

Co-Diagnostics Utilizes CoPrimer Platform to Design New Coronavirus Detection Test

Molecular diagnostics company Co-Diagnostics' shares opened more than 144% higher after the firm reported it has designed a test for virus detection of the new coronavirus, 2019-nCoV, using its CoPrimer™ platform. In the wake of widespread news and worldwide concerns ...
Streetwise Reports | January 24, 2020 |

Enzo Biochem Shares Rise 60% as the Firm Commences COVID-19 Lab Testing

Shares of Enzo Biochem traded higher after the company advised that they will launch coronavirus testing services starting next week. Enzo Biochem Inc. (ENZ:NYSE) today announced that "its wholly owned subsidiary, Enzo Clinical Labs Inc., will begin accep...
Streetwise Reports | March 9, 2020 |

Acceleration of COVID-19 Vaccine Programs Could Benefit U.S. Biotech

The development timeline for Inovio Pharmaceuticals' coronavirus vaccine candidate is discussed in an H.C. Wainwright & Co. report. In a May 8 research note, H.C. Wainwright & Co. analyst Ram Selvaraju wrote that the efforts being made in general to accelerate deve...
Streetwise Reports | May 14, 2020 |

A Market ‘Game Changer’ for Rapid COVID-19 At-Home Testing?

(Click image to play video) While we can finally see light at the end of the tunnel in the fight against COVID-19, the global pandemic has invariably changed how we interact with the world around us. The two big names when it comes to fighting the virus are ...
Dave Jackson | March 23, 2021 |
1 2 3 4 5 6 7 8 9 10 ...